Characteristics of the immunogenicity and tumor immune microenvironment in HER2 -amplified lung adenocarcinoma.

Frontiers in immunology(2022)

引用 4|浏览5
暂无评分
摘要
Patients with -amplified LUAD have better immunogenicity and/or an inflamed TIME among -aberrant tumors. Our study may provide clues for establishing the benefits and uses of ICIs for patients with this disease.
更多
查看译文
关键词
HER2,amplification,immunogenicity,lung adenocarcinoma,tumor immune microenvironment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要